Cargando…
Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells
Acyl-CoA synthetase 4 (ACSL4) overexpression plays a causal role in the aggressiveness of triple negative breast cancer. In turn, a negative correlation has been established between ACSL4 and estrogen receptor alpha (ERα) expression. However, the upstream regulatory mechanisms leading to differentia...
Autores principales: | Dattilo, Melina A., Benzo, Yanina, Herrera, Lucía M., Prada, Jesica G., Castillo, Ana F., Orlando, Ulises D., Podesta, Ernesto J., Maloberti, Paula M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635356/ https://www.ncbi.nlm.nih.gov/pubmed/31311992 http://dx.doi.org/10.1038/s41598-019-46776-7 |
Ejemplares similares
-
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
por: Orlando, Ulises D., et al.
Publicado: (2015) -
Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells
por: Maloberti, Paula M., et al.
Publicado: (2010) -
The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target
por: Orlando, Ulises D., et al.
Publicado: (2012) -
Giardia fatty acyl-CoA synthetases as potential drug targets
por: Guo, Fengguang, et al.
Publicado: (2015) -
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2019)